Germline burden of rare damaging variants negatively affects human healthspan and lifespan

  1. Anastasia V Shindyapina
  2. Aleksandr A Zenin
  3. Andrei E Tarkhov
  4. Didac Santesmasses
  5. Peter O Fedichev  Is a corresponding author
  6. Vadim N Gladyshev  Is a corresponding author
  1. Brigham and Women's Hospital, Harvard Medical School, United States
  2. Gero LLC, Russian Federation

Abstract

Heritability of human lifespan is 23-33% as evident from twin studies. Genome-wide association studies explored this question by linking particular alleles to lifespan traits. However, genetic variants identified so far can explain only a small fraction of lifespan heritability in humans. Here, we report that the burden of rarest protein-truncating variants (PTVs) in two large cohorts is negatively associated with human healthspan and lifespan, accounting for 0.4 and 1.3 years of their variability, respectively. In addition, longer-living individuals possess both fewer rarest PTVs and less damaging PTVs. We further find that somatic accumulation of PTVs accounts for only a small fraction of mortality and morbidity acceleration and hence is unlikely to be causal in aging. We conclude that rare damaging mutations, both inherited and accumulated throughout life, contribute to the aging process, and that burden of ultra-rare variants in combination with common alleles better explain apparent heritability of human lifespan.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1 and 3.

The following previously published data sets were used

Article and author information

Author details

  1. Anastasia V Shindyapina

    Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  2. Aleksandr A Zenin

    Research Division, Gero LLC, Moscow, Russian Federation
    Competing interests
    Aleksandr A Zenin, Employed by Gero LLC.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1522-0359
  3. Andrei E Tarkhov

    Research Division, Gero LLC, Moscow, Russian Federation
    Competing interests
    Andrei E Tarkhov, Employed by Gero LLC.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3350-4785
  4. Didac Santesmasses

    Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  5. Peter O Fedichev

    Research Division, Gero LLC, Moscow, Russian Federation
    For correspondence
    peter.fedichev@gero.ai
    Competing interests
    Peter O Fedichev, Founder of Gero LLC.
  6. Vadim N Gladyshev

    Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, United States
    For correspondence
    vgladyshev@rics.bwh.harvard.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0372-7016

Funding

National Institute on Aging (AG047745)

  • Vadim N Gladyshev

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Deidentified exome sequences were analyzed

Copyright

© 2020, Shindyapina et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,267
    views
  • 831
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anastasia V Shindyapina
  2. Aleksandr A Zenin
  3. Andrei E Tarkhov
  4. Didac Santesmasses
  5. Peter O Fedichev
  6. Vadim N Gladyshev
(2020)
Germline burden of rare damaging variants negatively affects human healthspan and lifespan
eLife 9:e53449.
https://doi.org/10.7554/eLife.53449

Share this article

https://doi.org/10.7554/eLife.53449

Further reading

    1. Chromosomes and Gene Expression
    2. Cell Biology
    Edited by Matt Kaeberlien et al.
    Collection

    eLife is pleased to present a Special Issue to highlight recent advances in the mechanistic understanding of aging and interventions that extend longevity.

    1. Genetics and Genomics
    Mengjia Li, Hengchao Zhang ... Lixiang Chen
    Research Article

    Isocitrate dehydrogenase 1 (IDH1) is the key enzyme that can modulate cellular metabolism, epigenetic modification, and redox homeostasis. Gain-of-function mutations and decreased expression of IDH1 have been demonstrated to be associated with pathogenesis of various myeloid malignancies characterized by ineffective erythropoiesis, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, the function and mechanism of IDH1 in human erythropoiesis still remains unclear. Here, utilizing the human erythropoiesis system, we present an evidence of IDH1-mediated chromatin state reprogramming besides its well-characterized metabolism effects. We found that knockdown IDH1 induced chromatin reorganization and subsequently led to abnormalities biological events in erythroid precursors, which could not be rescued by addition of reactive oxygen species (ROS) scavengers or supplementation of α-ketoglutarate (α-KG).We further revealed that knockdown IDH1 induces genome-wide changes in distribution and intensity of multiple histone marks, among which H3K79me3 was identified as a critical factor in chromatin state reprogramming. Integrated analysis of ChIP-seq, ATAC-seq, and RNA-seq recognized that SIRT1 was the key gene affected by IDH1 deficiency. Thus, our current work provided novel insights for further clarifying fundamental biological function of IDH1 which has substantial implications for an in-depth understanding of pathogenesis of diseases with IDH1 dysfunction and accordingly development of therapeutic strategies.